Joy Welham1, Matti Isohanni, Peter Jones, John McGrath. 1. Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD 4076, Australia. john_mcgrath@qcmhr.uq.edu.au
Abstract
BACKGROUND: Birth cohort (BC) studies demonstrate that individuals who develop schizophrenia differ from the general population on a range of developmental indices. The aims of this article were to summarize key findings from BC studies in order to identify areas of convergence and to outline areas requiring further research. METHOD: We define BC studies as studies based on general population BCs where data are collected prospectively from birth or childhood and which identify schizophrenia or related disorders as an outcome. To identify such studies, we searched various electronic databases using the search parameters (schizo* OR psych*) AND (birth cohort). We also checked the references of relevant articles and previous reviews. RESULTS: We identified 11 BCs from 7 countries that have examined schizophrenia as an outcome in adulthood. There is relatively consistent evidence that, as a group, children who later develop schizophrenia have behavioral disturbances and psychopathology, intellectual and language deficits, and early motor delays. Evidence with respect to alterations in language, educational performance, and physical growth has also been identified in some studies. BC studies have also contributed evidence about a wide range of putative risk factors for schizophrenia. CONCLUSIONS: BC studies have provided important, convergent insights into how the developmental trajectory of individuals who develop schizophrenia differs from their peers. The combination of new paradigms and larger cohorts, with the tools of modern epidemiology and biomedical science, is advancing our understanding of the developmental pathways to schizophrenia.
BACKGROUND: Birth cohort (BC) studies demonstrate that individuals who develop schizophrenia differ from the general population on a range of developmental indices. The aims of this article were to summarize key findings from BC studies in order to identify areas of convergence and to outline areas requiring further research. METHOD: We define BC studies as studies based on general population BCs where data are collected prospectively from birth or childhood and which identify schizophrenia or related disorders as an outcome. To identify such studies, we searched various electronic databases using the search parameters (schizo* OR psych*) AND (birth cohort). We also checked the references of relevant articles and previous reviews. RESULTS: We identified 11 BCs from 7 countries that have examined schizophrenia as an outcome in adulthood. There is relatively consistent evidence that, as a group, children who later develop schizophrenia have behavioral disturbances and psychopathology, intellectual and language deficits, and early motor delays. Evidence with respect to alterations in language, educational performance, and physical growth has also been identified in some studies. BC studies have also contributed evidence about a wide range of putative risk factors for schizophrenia. CONCLUSIONS: BC studies have provided important, convergent insights into how the developmental trajectory of individuals who develop schizophrenia differs from their peers. The combination of new paradigms and larger cohorts, with the tools of modern epidemiology and biomedical science, is advancing our understanding of the developmental pathways to schizophrenia.
Authors: Matti Isohanni; Erika Lauronen; Kristiina Moilanen; Irene Isohanni; Liisa Kemppainen; Hannu Koponen; Jouko Miettunen; Pirjo Mäki; Sami Räsänen; Juha Veijola; Pekka Tienari; Karl-Erik Wahlberg; Graham K Murray Journal: Br J Psychiatry Suppl Date: 2005-08
Authors: Nicholas C Stefanis; Thomas A Trikalinos; Dimitrios Avramopoulos; Nikos Smyrnis; Ioannis Evdokimidis; Evangelia E Ntzani; John P Ioannidis; Costas N Stefanis Journal: Biol Psychiatry Date: 2007-03-06 Impact factor: 13.382
Authors: Mark Weiser; Abraham Reichenberg; Jonathan Rabinowitz; Daniella Nahon; Efrat Kravitz; Gad Lubin; Haim Y Knobler; Michael Davidson; Shlomo Noy Journal: J Nerv Ment Dis Date: 2007-11 Impact factor: 2.254
Authors: Kaisa M Saari; Sari M Lindeman; Kaisa M Viilo; Matti K Isohanni; Marjo-Riitta Järvelin; Liisa H Laurén; Markku J Savolainen; Hannu J Koponen Journal: J Clin Psychiatry Date: 2005-05 Impact factor: 4.384
Authors: Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni Journal: Schizophr Bull Date: 2008-11-17 Impact factor: 9.306
Authors: David Freedman; Yuanyuan Bao; William S Kremen; Sophia Vinogradov; Ian W McKeague; Alan S Brown Journal: Schizophr Bull Date: 2012-02-29 Impact factor: 9.306
Authors: Guilherme Polanczyk; Terrie E Moffitt; Louise Arseneault; Mary Cannon; Antony Ambler; Richard S E Keefe; Renate Houts; Candice L Odgers; Avshalom Caspi Journal: Arch Gen Psychiatry Date: 2010-04
Authors: Ashleigh Lin; Patsy Di Prinzio; Deidra Young; Peter Jacoby; Andrew Whitehouse; Flavie Waters; Assen Jablensky; Vera A Morgan Journal: Schizophr Bull Date: 2016-04-30 Impact factor: 9.306